within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H01B_PosteriorPituitaryLobeHormones.H01BB02_Oxytocin;

model Oxytocin
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 5e-06,
    adminDuration = 600,
    adminMass = 5 / 1000000,
    adminCount = 1,
    Vd = 0.012,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.03,
    k12 = 6.944444444444445e-06,
    k21 = 6.944444444444445e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Oxytocin</td></tr><tr><td>ATC code:</td><td>H01BB02</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>5</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>12</td><td>L</td></tr>
    <tr><td>clearance:</td><td>18</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Oxytocin is a peptide hormone and medication used to induce labor, strengthen labor contractions, control bleeding after childbirth, and to induce abortion. As a drug, it is administered intravenously or intramuscularly. It is approved and widely used in obstetric practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy postpartum women following intravenous bolus administration.</p><h4>References</h4><ol><li><p>Shafer, SL, et al., &amp; Eisenach, JC (2025). Plasma pharmacokinetics of intravenous and intranasal oxytocin in nonpregnant adults. <i>British journal of anaesthesia</i> 134(5) 1513–1522. DOI:<a href=\"https://doi.org/10.1016/j.bja.2024.12.046\">10.1016/j.bja.2024.12.046</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40121179/\">https://pubmed.ncbi.nlm.nih.gov/40121179</a></p></li><li><p>Yu, Z, et al., &amp; Zhao, Y (2024). Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic-pharmacodynamic model of uterine contraction frequency. <i>Pharmacotherapy</i> 44(4) 319–330. DOI:<a href=\"https://doi.org/10.1002/phar.2911\">10.1002/phar.2911</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38419599/\">https://pubmed.ncbi.nlm.nih.gov/38419599</a></p></li><li><p>Nielsen, EI, et al., &amp; Uvnäs-Moberg, K (2017). Population Pharmacokinetic Analysis of Vaginally and Intravenously Administered Oxytocin in Postmenopausal Women. <i>Journal of clinical pharmacology</i> 57(12) 1573–1581. DOI:<a href=\"https://doi.org/10.1002/jcph.961\">10.1002/jcph.961</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28679021/\">https://pubmed.ncbi.nlm.nih.gov/28679021</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.H.H01BB02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Oxytocin;
